methylphenidate hydrochloride

Poland

Drugs containing this active substance

  • ADEHADER

    The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 5 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • ADEHADER

    The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when other methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 10 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • ADEHADER

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 20 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • ADEHADER

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 30 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • ADEHADER

    The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 40 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • ADEHADER

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 50 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • ADEHADER

    The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 60 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • ATENZA

    It is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents over 6 years of age and in adults. It may help improve attention and concentration and reduce impulsive behavior.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 14.76 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Liconsa S.A.

  • ATENZA

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents over 6 years of age and in adults. It is used after previous attempts at treatment with non-drug methods, such as behavioral therapy or psychological counseling.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 27 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Liconsa S.A.

  • ATENZA

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents over 6 years of age and in adults. It is used after previous attempts to treat with non-drug methods, such as behavioral therapy or psychological counseling.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 36 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Liconsa S.A.

  • ATENZA

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents over 6 years of age and in adults. It is used after previous attempts at treatment with non-drug methods, such as behavioral therapy or psychological counseling.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 54 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Liconsa S.A.

  • ATENZA

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents over 6 years of age and in adults. It is used after previous attempts at treatment with non-pharmacological methods, such as behavioral therapy or psychological counseling.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 44.28 mg
    methylphenidate hydrochloride 8.5 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Liconsa S.A.

  • CONCERTA

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used as an adjunct to therapeutic programs (psychological, educational, or environmental) after non-pharmacological methods have been tried.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 18 mg

    ATC: N06BA04

    Manufacturer: Janssen Pharmaceutica N.V.

  • CONCERTA

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used after non-pharmacological methods, such as behavioral therapy or psychological counseling, have been tried.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 36 mg

    ATC: N06BA04

    Manufacturer: Janssen Pharmaceutica N.V.

  • MEDIKINET 10 MG

    The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years. It helps to improve concentration, focus, and reduce impulsive behavior.

    Form: tablets

    Active substance Dosage
    methylphenidate hydrochloride 10 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET 20 MG

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years. It helps to improve concentration, extend attention span, and reduce impulsive behavior.

    Form: tablets

    Active substance Dosage
    methylphenidate hydrochloride 20 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET 5 MG

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years. It helps to improve concentration, extend attention span, and reduce impulsive behavior.

    Form: tablets

    Active substance Dosage
    methylphenidate hydrochloride 5 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET CR 10 MG

    The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 10 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET CR 20 MG

    The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 20 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET CR 30 MG

    The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 30 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET CR 40 MG

    The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 40 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET CR 5 MG

    The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It helps to improve concentration, extend attention span, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 5 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET CR 50 MG

    The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 50 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MEDIKINET CR 60 MG

    The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 60 mg

    ATC: N06BA04

    Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG

  • MINDETRA

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used after trying non-pharmacological methods, such as behavioral therapy or psychological counseling.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 18 mg

    ATC: N06BA04

    Manufacturer: Balkanpharma-Dupnitsa AD

  • MINDETRA

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used as an adjunct to psychological, educational, or environmental therapy, after non-pharmacological methods have previously been tried.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 27 mg

    ATC: N06BA04

    Manufacturer: Balkanpharma-Dupnitsa AD

  • MINDETRA

    It is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. The medicine may help to prolong and increase the ability to concentrate and to reduce impulsive behavior.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 36 mg

    ATC: N06BA04

    Manufacturer: Balkanpharma-Dupnitsa AD

  • MINDETRA

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used as an adjunct to psychological, educational, or environmental therapy, usually after non-pharmacological methods have been tried.

    Form: tablets, prolonged release

    Active substance Dosage
    methylphenidate hydrochloride 54 mg

    ATC: N06BA04

    Manufacturer: Balkanpharma-Dupnitsa AD

  • SYMKINET MR

    The medicine is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years and in adults.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 10 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Rubio S.A.

  • SYMKINET MR

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 20 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Rubio S.A.

  • SYMKINET MR

    It is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It may help improve attention and concentration and reduce impulsive behavior.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 30 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Rubio S.A.

  • SYMKINET MR

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.

    Form: capsules, hard modified release

    Active substance Dosage
    methylphenidate hydrochloride 40 mg

    ATC: N06BA04

    Manufacturer: Laboratorios Rubio S.A.